伊匹妥英 T1860

Product Introduction
Bioactivity


英文名: Imepitoin

描述: Imepitoin (AWD 131-138) 是一种新型的低亲和力部分苯二氮卓受体激动剂，有抗惊厥和抗焦虑作用。

激酶实验: Cell-based determinations of mTOR inhibition: A high-throughput screening cell-based assay is developed using MDA-MB-468 cells to detect mTORC1 and mTORC2 activity. Cells are exposed for 2 hours to increasing concentrations of AZD8055. At the end of the incubation period, cells are fixed, washed, and probed with antibodies against S473 pAkt or against S235/236 phosphorylated S6 (pS6). Levels of phosphorylation are assessed using an Acumen laser scanning cytometer.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 13 mg/mL (46.48 mM)


关键字: Imepitoin | Inhibitor | Gamma-aminobutyric acid Receptor | ELB138 | GABA Receptor | ELB 138 | γ-Aminobutyric acid Receptor | inhibit

相关产品: CGP 36742 | Guvacine hydrochloride | BPDBA | Dihydroergotoxine mesylate | MmTx1 toxin | Progabide | NS11394 | 2'MeO6MF | Bicuculline | Chlormezanone

相关库: Drug Repurposing Compound Library | Anti-Neurodegenerative Disease Compound Library | Anti-Parkinson's Disease Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Antidepressant Compound Library | Human Metabolite Library | Anti-Cancer Clinical Compound Library | NO PAINS Compound Library

伊匹妥英 T1860信息由TargetMol中国为您提供，如您想了解更多关于伊匹妥英 T1860报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途